Roger C. Kockelbergh
Leicester, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Transdermal Estradiol Patches in Locally Advanced Prostate Cancer.
Journal: The New England journal of medicine
Published: March 25, 2026
Preferences between three options for androgen deprivation therapy: a focus group study.
Journal: BJU international
Published: July 31, 2025
Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment.
Journal: NEJM evidence
Published: February 06, 2024
The sex gap in bladder cancer survival - a missing link in bladder cancer care?
Journal: Nature reviews. Urology
Published: July 17, 2023
A Repurposing Programme Evaluating Transdermal Oestradiol Patches for the Treatment of Prostate Cancer Within the PATCH and STAMPEDE Trials: Current Results and Adapting Trial Design.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: July 03, 2023
Patient experience of bladder cancer: A data linkage study.
Journal: BJUI compass
Published: May 31, 2023
Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.
Journal: The New England journal of medicine
Published: March 13, 2023
Healthcare systems data in the context of clinical trials - A comparison of cardiovascular data from a clinical trial dataset with routinely collected data.
Journal: Contemporary clinical trials
Published: November 18, 2022
The experience of UK patients with bladder cancer during the second wave of the COVID-19 pandemic.
Journal: BJUI compass
Published: February 11, 2022
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study).
Journal: BJU international
Published: December 15, 2021
The experience of UK patients with bladder cancer during the COVID-19 pandemic: a survey-based snapshot.
Journal: BJU international
Published: October 30, 2020
Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme.
Journal: Lancet (London, England)
Published: September 18, 2020
Last Updated: 09/26/2026